Palvella Therapeutics (PVLA) Return on Sales: 2015-2024
Historic Return on Sales for Palvella Therapeutics (PVLA) over the last 10 years, with Dec 2024 value amounting to -18.33%.
- Palvella Therapeutics' Return on Sales fell 1810.00% to -18.33% in Q4 2024 from the same period last year, while for Dec 2024 it was -18.33%, marking a year-over-year decrease of 1810.00%. This contributed to the annual value of 40.54% for FY2024, which is 4011.00% up from last year.
- Latest data reveals that Palvella Therapeutics reported Return on Sales of -18.33% as of Q4 2024, which was down 105,853.71% from 0.02% recorded in Q3 2024.
- In the past 5 years, Palvella Therapeutics' Return on Sales ranged from a high of 0.06% in Q1 2024 and a low of -18.33% during Q4 2024.
- For the 3-year period, Palvella Therapeutics' Return on Sales averaged around -2.75%, with its median value being -1.48% (2022).
- Examining YoY changes over the last 5 years, Palvella Therapeutics' Return on Sales showed a top increase of 304bps in 2024 and a maximum decrease of 1,810bps in 2024.
- Quarterly analysis of 5 years shows Palvella Therapeutics' Return on Sales stood at -1.14% in 2020, then plummeted by 66bps to -1.80% in 2021, then rose by 16bps to -1.64% in 2022, then skyrocketed by 140bps to -0.23% in 2023, then plummeted by 1,810bps to -18.33% in 2024.
- Its Return on Sales was -18.33% in Q4 2024, compared to 0.02% in Q3 2024 and 0.06% in Q1 2024.